Matches in Nanopublications for { ?s ?p "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 13 of
13
with 100 items per page.
- NP211967.RAvDXxFX6MiOx2rsDaUZIJdDebyuAtM9ociK-YLVMpaEQ130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211967.RAvDXxFX6MiOx2rsDaUZIJdDebyuAtM9ociK-YLVMpaEQ130_provenance.
- NP610131.RADB-hUwdPNmIYZl1Ptu3dHLrxbHEntA61QvUrsQ1f4lc130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610131.RADB-hUwdPNmIYZl1Ptu3dHLrxbHEntA61QvUrsQ1f4lc130_provenance.
- NP399313.RAzOib4mX4fJLQCQOykY-GofIFWL9gNHkAYtktxbJSAsI130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP399313.RAzOib4mX4fJLQCQOykY-GofIFWL9gNHkAYtktxbJSAsI130_provenance.
- NP607036.RAxzNTWtT06lZJTuwIc2dusEyIqxJgVsLdz6iohY771n8130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607036.RAxzNTWtT06lZJTuwIc2dusEyIqxJgVsLdz6iohY771n8130_provenance.
- NP720444.RALNxUq4zzPRwLJbwpONsHgeLBH8OnBQq4_V5JqQKNPTs130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720444.RALNxUq4zzPRwLJbwpONsHgeLBH8OnBQq4_V5JqQKNPTs130_provenance.
- NP811329.RAGG_WcSRhKVaRZuNeitNm1vLe2cNPqmbhZYWYz0mn_QA130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811329.RAGG_WcSRhKVaRZuNeitNm1vLe2cNPqmbhZYWYz0mn_QA130_provenance.
- NP1015539.RA3LBaQEaW3V4K3aBVyDHyl7xE9yC5VP69jKmwZ8x8mhI130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015539.RA3LBaQEaW3V4K3aBVyDHyl7xE9yC5VP69jKmwZ8x8mhI130_provenance.
- assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP865646.RAs_4QOjnVN_1a26ADGQO8Vp4w5ksdyDjwpJ68foGpI7g130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865646.RAs_4QOjnVN_1a26ADGQO8Vp4w5ksdyDjwpJ68foGpI7g130_provenance.
- NP965305.RAp4FLtcnT6OcDZHtQH5bvSNT0zOK1YFqt1It_iaoWJL4130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965305.RAp4FLtcnT6OcDZHtQH5bvSNT0zOK1YFqt1It_iaoWJL4130_provenance.
- NP516837.RAtVsVb6DEKbsv1EpdolrUeFQ80aq7xnekBbHAptOInKE130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516837.RAtVsVb6DEKbsv1EpdolrUeFQ80aq7xnekBbHAptOInKE130_provenance.
- NP516840.RAosgLo01oha9nKpaWw7QgfgcNs4UOGFACTeY-Uw3C-5o130_assertion description "[While ULBP2 binds the activating NK receptor NKG2D, the BB4 moiety binds to CD138, which is overexpressed on a variety of malignancies, including MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516840.RAosgLo01oha9nKpaWw7QgfgcNs4UOGFACTeY-Uw3C-5o130_provenance.